PBAC Public Summary Documents - November 2020 meeting

5 March 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2020 PBAC ...

Read more →

EMA and Health Canada publish clinical data used to support their authorisations of the Moderna COVID-19 vaccine

2 March 2021 - Openness and transparency are key to building confidence in COVID-19 vaccines. Today, EMA and Health Canada ...

Read more →

DoH updates agenda for March 2021 PBAC meeting

23 February 2021 - We are now up to version 5. ...

Read more →

EMA publishes agenda for 22-25 February CHMP meeting

22 February 2021 - The EMA has published a draft agenda for this week's CHMP meeting. ...

Read more →

Post-market review of medicines for smoking cessation – stakeholder forum outcome

15 February 2021 - A stakeholder forum was held for the post-market review of medicines for smoking cessation via webinar on ...

Read more →

Agenda for the March 2021 PBAC meeting

15 February 2021 - A revised agenda for the March 2021 PBAC meeting is now available. ...

Read more →

New toolbox available for EMA's PRIME designees

2 February 2021 - The European Medicines Agency has released a draft guidance to assist drug developers using its Priority ...

Read more →

ICER publishes evidence report on roxadustat for treating anaemia in chronic kidney disease

28 January 2021 - Other than a proven ability to reduce the need for intravenous iron supplements, the evidence is insufficient ...

Read more →

EMA publishes agenda for 25-29 January CHMP meeting

25 January 2021 - The EMA has published a draft agenda for this week's CHMP meeting. ...

Read more →

ICER publishes evidence report on therapies for high cholesterol

22 January 2021 - The evidence suggests that inclisiran can substantially lower LDL-C with limited safety concerns, and with a ...

Read more →

ICER releases draft evidence report on therapies for lupus nephritis

22 January 2021 - Public comment period now open until 18 February 2021; requests to make oral comment during public meeting ...

Read more →

2021 April price disclosure cycle – indicative prices

20 January 2021 - Indicative 1 April 2021 prices resulting from the 2021 April Cycle of Price Disclosure have now been ...

Read more →

PBAC Public Summary Documents (rejections/deferrals/other matters) - September 2020 intracycle meeting

15 January 2021 - The Public Summary Documents (rejections/deferrals/other matters) from the September 2020 PBAC untracycle meeting are now available. ...

Read more →

Further insights from the agenda for the 2021/1 PBAC meeting

13 January 2021 - The case for improved clarity and transparency gets stronger. ...

Read more →

DoH publishes revised agenda for March 2021 PBAC meeting

11 January 2021 - The initial agenda was revised within 24 hours of publication on the PBS website. ...

Read more →